Vascularized 3D printed scaffolds for promoting bone regeneration.

3D printed scaffolds hold promising perspective for bone tissue regeneration. Inspired by process of bone development stage, 3D printed scaffolds with rapid internal vascularization ability and robust osteoinduction bioactivity will be an ideal bone substitute for clinical use. Here, we fabricated a 3D printed biodegradable scaffold that can control release deferoxamine, via surface aminolysis and layer-by-layer assembly technique, which is essential for angiogenesis and osteogenesis and match to bone development and reconstruction. Our in vitro studies show that the scaffold significantly accelerates the vascular pattern formation of human umbilical endothelial cells, boosts the mineralized matrix production, and the expression of osteogenesis-related genes during osteogenic differentiation of mesenchymal stem cells. In vivo results show that deferoxamine promotes the vascular ingrowth and enhances the bone regeneration at the defect site in a rat large bone defect model. Moreover, this 3D-printed scaffold has excellent biocompatibility that is suitable for mesenchymal stem cells grow and differentiate and possess the appropriate mechanical property that is similar to natural cancellous bone. In summary, this 3D-printed scaffold holds huge potential for clinical translation in the treatment of segmental bone defect, due to its flexibility, economical friendly and practicality.

[1]  D. Kaplan,et al.  Injectable hydrogel systems with multiple biophysical and biochemical cues for bone regeneration. , 2020, Biomaterials science.

[2]  Dong Zhai,et al.  Three-Dimensional Printing of Hollow-Struts-Packed Bioceramic Scaffolds for Bone Regeneration. , 2015, ACS applied materials & interfaces.

[3]  A. Akbarzadeh,et al.  Assessment of polycaprolacton (PCL) nanocomposite scaffold compared with hydroxyapatite (HA) on healing of segmental femur bone defect in rabbits , 2017, Artificial cells, nanomedicine, and biotechnology.

[4]  K. Kozloff,et al.  Deferoxamine Restores Callus Size, Mineralization, and Mechanical Strength in Fracture Healing after Radiotherapy , 2013, Plastic and reconstructive surgery.

[5]  Chao Wan,et al.  The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. , 2007, The Journal of clinical investigation.

[6]  S. Kang,et al.  Bone-Healing Capacity of PCL/PLGA/Duck Beak Scaffold in Critical Bone Defects in a Rabbit Model , 2016, BioMed research international.

[7]  Ivan Martin,et al.  Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. , 2006, Tissue engineering.

[8]  J. Porter Deferoxamine pharmacokinetics. , 2001, Seminars in hematology.

[9]  Xiaofeng Jia,et al.  Engineering anatomically shaped vascularized bone grafts with hASCs and 3D-printed PCL scaffolds. , 2014, Journal of biomedical materials research. Part A.

[10]  P. Carmeliet,et al.  Adequate hypoxia inducible factor 1α signaling is indispensable for bone regeneration. , 2016, Bone.

[11]  Chao Wan,et al.  Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[12]  Jieun Jung,et al.  Hypoxia Inducible Factor-1α Regulates the Migration of Bone Marrow Mesenchymal Stem Cells via Integrin α 4 , 2016, Stem cells international.

[13]  Haiyan Wang,et al.  Hypoxia-inducible factor-1α antagonizes the hypoxia-mediated osteoblast cell viability reduction by inhibiting apoptosis. , 2015, Experimental and therapeutic medicine.

[14]  R. Adams,et al.  Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone , 2014, Nature.

[15]  L. Deng,et al.  Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1 , 2016, Cell Death and Disease.

[16]  A. Donneys,et al.  Targeting angiogenesis as a therapeutic means to reinforce osteocyte survival and prevent nonunions in the aftermath of radiotherapy , 2015, Head & neck.

[17]  J. Barralet,et al.  * Hypoxia Biomimicry to Enhance Monetite Bone Defect Repair. , 2017, Tissue engineering. Part A.

[18]  Peng Jia,et al.  Deferoxamine released from poly(lactic-co-glycolic acid) promotes healing of osteoporotic bone defect via enhanced angiogenesis and osteogenesis. , 2016, Journal of biomedical materials research. Part A.

[19]  P. Bártolo,et al.  Effect of process parameters on the morphological and mechanical properties of 3D Bioextruded poly(ε‐caprolactone) scaffolds , 2012 .

[20]  Benjamin M Wu,et al.  Recent advances in 3D printing of biomaterials , 2015, Journal of Biological Engineering.

[21]  S. Buchman,et al.  Reply: deferoxamine restores callus size, mineralization, and mechanical strength in fracture healing after radiotherapy. , 2013, Plastic and reconstructive surgery.

[22]  R. Najafi,et al.  Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats , 2013, Expert opinion on biological therapy.

[23]  W. Świȩszkowski,et al.  Three‐dimensional printed polycaprolactone‐based scaffolds provide an advantageous environment for osteogenic differentiation of human adipose‐derived stem cells , 2018, Journal of tissue engineering and regenerative medicine.

[24]  T. Miramond,et al.  Osteoconduction, Osteogenicity, Osteoinduction, what are the fundamental properties for a smart bone substitutes , 2013 .

[25]  P. Babu,et al.  Isolation, characterization and differentiation potential of rat bone marrow stromal cells. , 2010, Neurology India.

[26]  Feng Chen,et al.  Enhanced osteogenesis and angiogenesis by mesoporous hydroxyapatite microspheres-derived simvastatin sustained release system for superior bone regeneration , 2017, Scientific Reports.

[27]  Warren L. Grayson,et al.  Comparison of 3D-Printed Poly-ɛ-Caprolactone Scaffolds Functionalized with Tricalcium Phosphate, Hydroxyapatite, Bio-Oss, or Decellularized Bone Matrix. , 2016, Tissue engineering. Part A.

[28]  A. Martínez-Richa,et al.  Hydrolytic degradation of poly(ε‐caprolactone) with different end groups and poly(ε‐caprolactone‐co‐γ‐butyrolactone): characterization and kinetics of hydrocortisone delivery , 2011 .

[29]  Richard O C Oreffo,et al.  The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. , 2010, Biomaterials.

[30]  Shaobing Zhou,et al.  In Situ Growth Kinetics of Hydroxyapatite on Electrospun Poly(DL-lactide) Fibers with Gelatin Grafted , 2008 .

[31]  M. Hadjiargyrou,et al.  Activation of the transcription factor HIF-1 and its target genes, VEGF, HO-1, iNOS, during fracture repair. , 2004, Bone.

[32]  J. Kanczler,et al.  Osteogenesis and angiogenesis: the potential for engineering bone. , 2008, European cells & materials.

[33]  Guangyao Liu,et al.  Engineered three-dimensional scaffolds for enhanced bone regeneration in osteonecrosis , 2020, Bioactive materials.

[34]  T. Clemens,et al.  Activation of the hypoxia-inducible factor-1α pathway accelerates bone regeneration , 2008, Proceedings of the National Academy of Sciences.

[35]  Jianzhong Fu,et al.  3D robocasting magnesium-doped wollastonite/TCP bioceramic scaffolds with improved bone regeneration capacity in critical sized calvarial defects. , 2017, Journal of materials chemistry. B.

[36]  S. Goldstein,et al.  Localized deferoxamine injection augments vascularity and improves bony union in pathologic fracture healing after radiotherapy. , 2013, Bone.

[37]  Yong-ping Su,et al.  Megakaryocytes promote bone formation through coupling osteogenesis with angiogenesis by secreting TGF-β1 , 2020, Theranostics.

[38]  D. Hutmacher,et al.  The return of a forgotten polymer : Polycaprolactone in the 21st century , 2009 .

[39]  Richard O C Oreffo,et al.  Bone tissue engineering: hope vs hype. , 2002, Biochemical and biophysical research communications.

[40]  Molly M. Stevens,et al.  Biomaterials for bone tissue engineering , 2008 .

[41]  M. Álvarez-Pérez,et al.  Polycaprolactone- and polycaprolactone/ceramic-based 3D-bioplotted porous scaffolds for bone regeneration: A comparative study. , 2017, Materials science & engineering. C, Materials for biological applications.

[42]  N. Shahrubudin,et al.  Challenges of 3D printing technology for manufacturing biomedical products: A case study of Malaysian manufacturing firms , 2020, Heliyon.

[43]  Bin Zhang,et al.  Effects of deferoxamine on the osteogenic differentiation of human periodontal ligament cells. , 2017, Molecular medicine reports.

[44]  K. Burg,et al.  Biomaterial developments for bone tissue engineering. , 2000, Biomaterials.

[45]  K. Kozloff,et al.  Prevention of radiation-induced bone pathology through combined pharmacologic cytoprotection and angiogenic stimulation. , 2016, Bone.

[46]  Youjia Xu,et al.  Synergistic protection of bone vasculature and bone mass by desferrioxamine in osteoporotic mice , 2017, Molecular medicine reports.

[47]  R. Zellweger,et al.  BONE MORPHOGENETIC PROTEINS IN CLINICAL APPLICATIONS , 2007, ANZ journal of surgery.

[48]  Shaobing Zhou,et al.  Controllable growth of hydroxyapatite on electrospun poly(dl-lactide) fibers grafted with chitosan as potential tissue engineering scaffolds , 2010 .

[49]  B. He,et al.  BMP9 exhibits dual and coupled roles in inducing osteogenic and angiogenic differentiation of mesenchymal stem cells , 2020, Bioscience reports.

[50]  Karim Oudina,et al.  Desferrioxamine‐driven upregulation of angiogenic factor expression by human bone marrow stromal cells , 2008, Journal of tissue engineering and regenerative medicine.

[51]  Yi-Chih Sun,et al.  VEGF modulates angiogenesis and osteogenesis in shockwave-promoted fracture healing in rabbits. , 2011, The Journal of surgical research.

[52]  J. Richtsmeier,et al.  Angiogenesis and intramembranous osteogenesis , 2013, Developmental dynamics : an official publication of the American Association of Anatomists.

[53]  I Zein,et al.  Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. , 2001, Journal of biomedical materials research.

[54]  E. Place,et al.  Complexity in biomaterials for tissue engineering. , 2009, Nature materials.

[55]  S. Buchman,et al.  Deferoxamine Enhances Bone Regeneration in Mandibular Distraction Osteogenesis , 2014, Plastic and reconstructive surgery.

[56]  L. Deng,et al.  Mechanically enhanced lipo-hydrogel with controlled release of multi-type drugs for bone regeneration , 2018, Applied Materials Today.

[57]  LiuLi-min,et al.  In Situ Release of VEGF Enhances Osteogenesis in 3D Porous Scaffolds Engineered with Osterix-Modified Adipose-Derived Stem Cells. , 2017, Tissue engineering. Part A.

[58]  P. Mohanan,et al.  Degradation of Poly(ε-caprolactone) and bio-interactions with mouse bone marrow mesenchymal stem cells. , 2018 .

[59]  Raquel Couto de Azevedo Gonçalves Mota,et al.  3D Printed Scaffolds as a New Perspective for Bone Tissue Regeneration: Literature Review , 2016 .

[60]  A. Giaccia,et al.  Age Decreases Endothelial Progenitor Cell Recruitment Through Decreases in Hypoxia-Inducible Factor 1α Stabilization During Ischemia , 2007, Circulation.

[61]  G. Semenza,et al.  Hypoxia-Inducible Factor 1 (HIF-1) Pathway , 2007, Science's STKE.

[62]  T. Albrektsson,et al.  Osteoinduction, osteoconduction and osseointegration , 2001, European Spine Journal.